跳至主要内容
临床试验/NL-OMON50922
NL-OMON50922已完成4 期

Effect of oral magnesium supplementation on insulin sensitivity in people with type 2 diabetes - Magnesium

Radboud Universitair Medisch Centrum0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • •* Clinical diagnosis of type 2 diabetes mellitus
  • •* Treatment with insulin for at least one year
  • •* Minimum age of 18 years
  • •* Ability to provide informed consent

排除标准

  • •* Treatment with more than 7.5 mg prednisone daily (or a comparable dose of
  • •other oral corticosteroids)
  • •* Use of magnesium supplementation in the week before screening
  • •* Any cardiovascular event in the six months before screening
  • •* Illnesses and unstable diseases that interfere with the primary outcome
  • •* Chronic diarrhea
  • •* Alcohol consumption of more than 14 units weekly
  • •* MDRD-GFR < 45 ml/min/1.73m2
  • •* Body-Mass Index < 18 or > 40 kg/m2
  • •* Pregnancy or the wish to become pregnant

研究者

相似试验